参考文献
1．中华医学会放射学分会，中国医师协会放射医师分会. 对比剂使用指南（第1版）.中华放射学杂志. 2008； 42（3）： 320-325. 2．胡大一等. 冠状动脉造影与临床（第1版）.辽宁科学技术出版社 2007. 3．2009对比剂肾病中国专家共识. 4．优维显?不良反应处理指南.
5．Al Ghonaim M，Pannu N. Prevention andtreatment of contrast-inducednephropathy. Tech Vasc Interv Radiol，2006，9： 42-49. 6．McCullough PA，Adam A，Becker CR，et al. Epidemiology and prognosticimplications of contrast-inducednephropathy. Am J Cardiol，2006； 98： 5K-13K. 7．McCullough P. Outcomes of contrast-inducednephropathy： experiencein patientsundergoingcardiovascularintervention. Catheter Cardiovasc Interv，2006； 67： 335-343. 8．Pannu N，Wiebe N，Tonelli M.Prophylaxis strategies for contrast-inducednephropathy. JAMA，2006； 295： 2765-2779. 9．ESUR对比剂指南. http：//www.esur.org/Contrast-media.51.0.html.
10．Namasivayam S，Kalra MK，Torres WE et al.Adverse reactions to intravenous iodinated
contrast media： a primer for radiologists.Emerg Radiol. 2006； 12（5）： 210-215. 11．Webb JA，Stacul F，Thomsen HS et al. Members of the Contrasr Media Safety Committee of
the European Society of Urogenital Radiology （ESUR）.Late adverse reactions to intravascular iodinated contrast media.Eur Radiol. 2003；13：181-184. 12．Tepel M，Aspelin P，Lameire N. Contrast-induced nephropathy： a clinical and
evidence-basedapproach. Circulation，2006； 113： 1799-1806. 13．Persson PB，Tepel M. Contrastmedium-inducednephropathy： thepathophysiology. Kidney Int
Suppl，2006； S8-S10. 14．Persson PB，Contrast-inducednephropathy （Review），Eur Radiol，2005； 15（Suppl 4）：
D65-D69. 15．Morcos SK，Thomsen HS. European society of urogenital radiology guidelines
onadmininstering contrastmedia. Abdom Imaging，2003，28： 187-190. 16．Elicker BM，Cypel YS，Weinreb JC. IV contrast administration for CT： asurvey of practices for the screening and prevention ofcontrastnephropathy. AJR，2006； 186： 1651-1658 17．Thomsen HS. Guidelines for contrast media from the European Society of U rogenital
Radiology. AJR Am J Roentgenol ， 2003； 181： 1463-1471. 18．Richared Solomon. Kidney International. 2005；（68）： 2256 – 2263.
26
19．American College of Radiology：Manual on contrast media（version 6）.2008.URL：http：
//www.acr.org/secondaryMainMenuCategories/quality_safety/contrast_manual.aspx. 20．van der Molen AJ，Thomsen HS，Morcos SK. Effect of iodinated contrast media on thyroid function in adults. Eur Radiol.2004；14（5）：902-907. 21．Yamaguchi K，Katayama H，Takashima T，et al. Prediction of severe adverse reactionto ionic
and nonionic contrastmediain Japan： evaluation of pretesting. Areport from the Japanese Committee on the Safety of Contrast Media. Radiology，1991； 178： 363-367. 22．Widmark JM. Imaging-relatedmedications： a class overvies. Proc（Bay Univ MedCent），
2007，20： 408-417. 23．Singh J，Daftary A.Iodinated contrast media and their adverse reactions：J Nucl Med Technol.
2008；36（2）：69-74. 24．Thomsen HS，Morcos SK. ESUR guidelines on contrast media.Abdom Imaging.2006；31（2）：131-14. 25．Thomsen HS，Morcos SK. Contrast-medium-inducednephropathy： isthere a new consensus?
Areviewofpublishedguidelines. EurRadiol，2006； 16： 1835-1840. 26．Toprak O. Conflicting andnewrisk factorsforcontrastinduced nephropathy（Review）. J Urol，
2007，178： 2277-2283. 27．Toprak O，Cirit M，Yesil M，et al. Impact of diabetic andprediabetic state ondevelopment of
contrast-induced nephropathy in patients with chronic kidneydisease. NephrolDial Transplant，2007，22： 819-826. 28．Rao QA，Newhouse JH. Riskofnephropathyafterintravenousadministrationofcontrastmaterial：
a criticalliteratureanalysis. Radiology，，2006； 239： 392-397. 29．Toprak O，Cirit M. Risk factors and therapystrategies for contrast-inducednephropathy. Ren Fail，2006； 28： 365-381. 30
．Katzberg RW，Barrett BJ. Risk ofiodinated contrastmaterial： inducednephropathywithintravenousadministration. Radiology，2007； 243： 622-628.
31．李彪，齐海海，裕东洁，等. Cockroft-Gault 公式和简化MDRD公式估算老年人肾功能
准确性的比较研究. 中华老年医学杂志，2007； 26： 97-100. 32．Lameire N，AdamA，Becher CR，et al. Baselinerenalfunctionscreening.Am J Cardiol，2006；
98： 21K-26K. 33．McCullough PA，Adam A，Becker C，et al. Risk prediction of contrast-induced nephropathy.
Am J Cardiol. 2006；98（6 suppl 1）：27-36. 34
．NamasivayamS，Kalra MK，TorresWE，et al. Adversereactionstointravenousiodinatedcontrastmedia： aprimerforradiologists. EmergRadiol，2006； 12：210-215.
35．Solomon R. The role ofosmolalityintheincidenceofcontrast-inducednephropathy：
27
asystemticreviewofangiographiccontrastmediainhighriskpatients. KidneyInt，2005； 68： 2256-2263.
36．Lameire N，Adam A，Becker C，et al. Baseline renal function screening. Am J Cardiol. 2006；
98（6 suppl 1）：21-26. 37．Ma YC，Li Z， Chen JH，et al. Modified Glomeruar Filtration Rate Estimating Equation for
Chinese Patients with Chronic Kidney Disease J Am Soc Nephrol. 2006；17：2937-2944. 38．急性ST段抬高心肌梗死PCI的专家共识.
39．Weisbord SD，Palevsky PM. Prevention of contrast-induced nephropathy with volume
expansion.Clin J Am Soc Nephrol. 2008；3： 273-280. 40．Mueller C，Buerkle G，Buettner HJ ，et al. Prevention of contrast media-associated
mephropathy： randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intem Med ，2002 ，，162 ：329-336. 41．Merten GJ ，Burgess WP，Gray LV ，et al Prevention of contrastinduced-induced
Nephropathy with sodium bicarbonate： a randomized controlled trial. JAMA，2004； 291： 2328-2334. 42．Solomon RJ，Natarajan MK，Doucet S，et al. Cardiac Angiography in Renally Impaired
Patients （CARE） study： a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007；115：3189 –96. 43．Reed M，Meier P，Tamhane UU，et al. The relative renal safety of iodixanol compared with
low-osmolar contrast media： a meta-analysis of randomized controlled trials. J Am Coll Cardiol Intv. 2009；2：645–54. 44．Heinrich MC，Haberle L，Muller V，et al. Nephrotoxicity of iso-osmolar iodixanol compared
with nonionic low-osmolar contrast media： metaanalysis of randomized controlled trials. Radiology. 2009；250：68–86. 45．Persson PB，Hansell P，Liss P. Pathophysiology of contrast medium-induced
nephropathy.Kidney Int. 2005；68（1）：14-22. 46．Fleischmann D. Use of high concentration contrast media： principles and rationale—vascular
district. Eur J Radiol. 2003；45：S88-S93. 47．Cademartiri F，Luccichenti G，Marano R，et al. Spiral CT-angiography with one，four，
and sixteen slice scanners. Technical note. Radiol Med （Torino）. 2003；106：269-283. 48．Campbell DR，Flemming BK，Mason WF，et al. A comparative study of the nephrotoxicity
of iohexol，iopamidol and ioxaglate in peripheral angiography. Can Assoc Radiol J. 1990；41：133-137. 49．Chanard J，Jolly D，Doco J. Nephrotoxicity of conventional and low osmolality radiocontrast media. J Nephrol. 1991；4：203-209. 50．Krumlovsky F，Simon N，Santhanam S. Acute renal failure （ARF） secondary to
administration of radiographic contrast material （RCM） [abstract]. Kidney Int. 1976；10：
28
501.
51．Krumlovsky FA，Simon N，Santhanam S，et al. Acute renal failure. Association with
administration of radiographic contrast material. JAMA. 1978；239：125-127. 52．Cochran ST，Wong WS，Roe DJ. Predicting angiography-induced acute renal function
impairment： clinical risk model. AJR Am J Roentgenol. 1983；141：1027-1033. 53．Guitterez NV，Diaz A，Timmis GC，et al. Determinants of serum creatinine trajectory in acute
contrast nephropathy. J Interv Cardiol. 2002； 15：349-354. 54．中华医学会心血管病学分会，，中华心血管病杂志编辑委员会. .经皮冠状动脉介入治疗
指南（2009 ）. 中华心血管病杂志. 2009； 37（1）： 4-25. 55．ECC Committee，Subcommittees and Task Forces of the American Heart Association. 2010
American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010；112（24 Suppl）： IV1-203.
29